Individuals living in malaria-endemic regions develop naturally Background: acquired immunity against severe malarial disease, but it is unclear whether immunity that affects the establishment of infections develops following continuous natural exposure.
In summary, functional antibodies against the pre-erythrocytic Conclusions: stages of malaria infection are acquired in children who are repeatedly exposed to parasites. This immune response does not prevent them from Plasmodium becoming infected during a malaria transmission season, but might delay the appearance of blood stage parasitaemia and consequently needs to be considered in the evaluation of malaria vaccines. 
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Introduction
The most advanced malaria vaccine, RTS,S (trade name, Mosquirix), induces immune responses that target P. falciparum circumsporozoite protein (CSP) and thereby the pre-erythrocytic stages of malaria 1 . Alongside the RTS,S subunit vaccine, several other pre-erythrocytic stage vaccines are under development, based on subunit or whole-parasite vaccination [2] [3] [4] [5] . Vaccination with the attenuated sporozoite vaccine PfSPZ resulted in a protective efficacy of ~48%, as quantified by differences in time to first positive blood smears in malaria-experienced adults in Mali 6 . The results of this and other vaccine trials and the efficient immunisation of malaria-naive individuals with multiple infected mosquito bites while receiving chloroquine 7 contrast with the limited epidemiological evidence of naturally acquired functional immunity to Plasmodium pre-erythrocytic stages. Individuals living in malaria-endemic regions can develop naturally acquired immunity against severe malaria disease and death 8, 9 , but it is unclear whether immunity that prevents or reduces infection incidence develops following natural exposure 9 . The high incidence of blood-stage re-infection after effective anti-malarial treatment in adults living in malaria-endemic regions suggests that sterilizing immunity does not develop even after years of repeated infection 10, 11 . Similarly, cohort studies that have analysed the relationship between age and risk of P. falciparum infection showed no evidence for complete protection against infection and conflicting evidence on whether naturally acquired immunity can result in a different time to patency 12, 13 . One of the most detailed studies on this topic reported clear negative associations between age and the risk of clinical malaria or microscopy-detected malaria infection, but similar times to PCR-detected infection for all age groups. The study concluded no or very limited evidence for an agedependent acquisition of immunity that protects from infection 13 .
Given the interest in pre-erythrocytic vaccines, studies are needed to understand natural protective immune responses that target sporozoite and liver-stages of malaria infection. Here, we determine the associations between responses affecting sporozoite gliding motility, hepatocyte invasion and malaria infection risk assessed by weekly quantitative PCR (qPCR) in a cohort of schoolchildren from Burkina Faso exposed to intense malaria transmission.
Results
Study population and follow-up
Of the 58 school-aged children who were recruited and received treatment at enrolment, 6 were PCR-positive 3 weeks after dihydroartemisinin-piperaquine (DHA-PQ) administration and were not eligible to continue follow-up. One child who was only followed for one routine visit, when no infection was detected, and who withdrew from the study, did not have immune responses quantified and was not included in this analysis.
Parasitological and immunological data from the remaining 51 intensively followed children were analysed (Table 1) . Every week these study participants were screened for incident infections. All but one study participant had P. falciparum parasites detected by 18S qPCR during follow-up. Malaria infection caused clinical disease in 43/50 children. One child developed symptomatology suggestive of malaria, but no parasites were detected in samples collected before and during the clinical episode; data from this child were censored after the onset of symptoms. The median time from confirmation of the absence of parasites (i.e. 3 weeks after anti-malarial treatment) to infection detection by nested PCR or onset of symptoms was 28 days; one child who did not have parasites detected by field PCR was not included in this calculation. Similarly, the median time to parasite detection by 18S qPCR was 30 days. In Figure 1 , both the times of first 18S qPCR positive result and, if applicable, of development of clinical disease are presented for all study participants.
Sporozoite-specific IgG and IgM antibodies in malariaexposed children Malaria antigen-specific antibodies to pre-erythrocytic antigens CSP, liver stage antigen (LSA-1) and to asexual lysate were determined in naturally exposed children and malaria-naive European donors by ELISAs. Antibody titres to the CSP preerythrocytic antigen were on average low in naturally exposed children and not significantly different from malaria-naive donors (Figure 2A , P=0.11; non-parametric tests were used for all comparisons), while LSA-1 antibody levels were significantly higher in malaria-exposed children compared to malaria-naive donors ( Figure 2B , P=0.006). As expected, asexual blood stage-specific antibody titers in naturally exposed children were higher compared to malaria-naive donors ( Figure 2C , P<0.0001). In addition to antigen-specific assays, IgG and IgM antibodies recognizing Plasmodium sporozoites were quantified using fluorescently labelled anti-IgG and anti-IgM antibodies by flow cytometric analysis. Whole sporozoite-specific IgG and IgM antibody levels in the study participants were significantly higher than in malaria-naive donors ( Figure 2D , E, P=0.02 and 0.004 for IgG and IgM, respectively). Strong correlations between sporozoite-specific IgG and IgM antibodies ( Figure S1A in Extended data 14 , P=0.0005, Spearman's ρ=0.75), and between CSP-IgG antibody levels and whole sporozoite-specific IgG antibodies (Figure S1B in Extended data 14 , Spearman's ρ=0.83, P<0.0001) were also observed.
Naturally acquired antibodies in children neutralize in vitro sporozoite gliding motility The neutralizing activity of naturally acquired antibodies against sporozoite motility was determined in an in vitro assay. Sporozoites pre-treated with PBS showed an average gliding trail surface of 7,392 (95% confidence interval [CI] 4,151-9,388) pixels. To characterize the effect of human plasma on sporozoite gliding motility that is independent of naturally acquired immunity, sporozoites were incubated in the presence of plasma from malaria-naive individuals (n=5) and showed an average gliding trail surface of 1,427(95% CI 646.6-2,207) pixels, which is considerably larger than the gliding trail surface of sporozoites incubated with 30 μg/ml of a monoclonal anti-CSP antibody, our positive control, 141 (95% CI 71.9-225.4) pixels.
Plasma from the majority of cohort participants reduced in vitro sporozoite gliding motility with a median gliding inhibition of 59.6% (IQR 27.8-77.0%); incubation of sporozoites with plasma from three participants resulted in lower gliding trail surfaces than the positive control. We defined two groups: one with poor gliding inhibition (individuals whose plasma inhibited less than 20% of sporozoite gliding motility, N=8) and the other with strong gliding inhibition (more than 80% gliding inhibition, N=8). .01, Spearman's ρ=0.61). While sporozoite-specific IgG and IgM antibody levels of poor gliding inhibitors did not significantly differ from malaria-naive adults, sporozoite-specific antibody levels of strong gliding inhibitors were significantly higher compared to poor gliding inhibitors ( Figure S2D in Extended data 14 , P<0.0001 and P=0.004 for IgG and IgM antibodies, respectively) and malaria-naive adults ( Figure S2D , E in Extended data 14 , P<0.0001 and P=0.0006 for IgG and IgM antibodies, respectively). This suggests that quantitative differences in measured immune responses might explain variation in these functional phenotypes.
Antibodies in malaria-exposed children neutralize in vitro sporozoite infectivity of hepatocytes The inhibitory effect of naturally acquired antibodies on in vitro sporozoite invasion of hepatocytes was also assessed in a selected number of samples shown to inhibit gliding motility strongly (n=8) or poorly (n=8). In vitro invasion was inhibited by naturally acquired antibodies (median invasion inhibition, 19.4% [IQR, 15.2-40.9%]), and plasma from children categorized as strong Figure 2 . Naturally acquired pre-erythrocytic antibody levels and their functionality against sporozoite infectivity in vitro. Malaria antigen-specific antibody levels in children from Burkina Faso (n=51) and European malaria-naive adults (n=9) to the pre-erythrocytic antigens (A) circumsporozoite protein (CSP), (B) liver-stage antigen-1 (LSA-1), and (C) asexual lysate as an internal control were determined by ELISAs and expressed as arbitrary units (AU). The amount of (D) IgG and (E) IgM antibodies recognizing sporozoites was determined by flow cytometry and shown as the geometric mean fluorescence intensity (MFI). To this end, P. falciparum NF54 sporozoites were pre-treated with 10% heat-inactivated plasma from children from Burkina Faso (n=17) and malaria-naive adults (n=8) and stained with fluorescently labelled antibodies against IgG and IgM antibodies. (F) The gliding motility of P. falciparum NF54 sporozoites, pre-treated with plasma from children from Burkina Faso (n=51 and malaria-naive adults (n=5), was determined by in vitro gliding motility assays. Gliding trail length of sporozoites incubated with plasma from malaria-naive donors (n=5) or naturally exposed children who were poor (n=8) or strong (n=8) inhibitors of gliding motility are shown. (G) The percent hepatocytes invaded by P. falciparum NF54 sporozoites pre-treated with plasma from children from Burkina Faso (n=16) who were shown to be either poor (n=8) or strong (n=8) gliding inhibitors and malaria-naive adults (n=9) was determined by in vitro invasion assays in human hepatoma cells. Comparisons between multiple groups were tested with Kruskal-Wallis test with Dunn's multiple comparison post hoc test. Evidence of natural risk-modifying pre-erythrocytic immunity For each immunological assay, ELISA or sporozoite gliding motility assays, children were categorized in two groups: participants with high antibody responses (or high sporozoite gliding inhibition activity) were those with assay values higher than the study population median ( Figure 3A) ; children considered to have low antibody responses or low sporozoite gliding inhibition capacity had values lower than the median. Based on this categorization, study subjects with high CSP responses and those whose plasma inhibited sporozoite gliding movement acquired blood-stage P. falciparum infection (qPCR-based parasitaemia ≥ 0.1 parasites/μl) later compared to children with lower CSP responses and less efficient gliding inhibitory activity ( Figure 3B ; P=0.05 and P=0.01 for CSP responses and sporozoite gliding inhibition, respectively). High anti-LSA-1 antibody levels, on the other hand, did not influence time to infection (P=0.31). Blood-stage immunity, i.e. high response in the asexual stage lysate assay, was also associated with longer time to PCR-detected infection ( Figure 3C , P=0.005). We repeated these analyses excluding children with haemoglobin S and haemoglobin C mutations, as these conditions might influence both immunity 15 and parasite carriage 16, 17 . Despite the limited number of individuals included in this analysis (n=36), similar results were obtained (P=0.01 for both CSP and asexual stage lysate assays and P=0.05 for the sporozoite gliding inhibition assay). Additional analyses (Extended data 14 ) show that functional responses against pre-erythrocytic stages were also associated with infection risk when different parasite density thresholds are used to define infection.
Since children with high CSP responses were more likely to have high antibody responses to asexual blood stage parasite lysate compared to low CSP responders (60% versus 38.5%, respectively; P=0.12), multivariate Cox models were fit to assess the mutually adjusted effects of these immune responses on time to infection detection (Table 2 ). While the relationship between anti-CSP responses and time to malaria infection was not statistically significant in a model that also included results of the asexual stage lysate assay, higher inhibition of in vitro sporozoite gliding motility remained associated with protection against falciparum infection after adjustment for bloodstage immunity (hazard ratio, 0.55; 95% CI, 0.29-1.01).
Discussion
In this longitudinal study in Burkina Faso, we analysed the associations between functional immune responses against pre-erythrocytic stages of malaria and the incidence of qPCRdetected infections in children aged 5-10 years. We observed that (i) schoolchildren develop antibody responses that can interfere with sporozoite motility and infectivity in vitro, and (ii) those children with antibodies that more efficiently reduced in vitro sporozoite gliding motility remained uninfected for longer periods of time. Our epidemiological data together with the in vitro data provide evidence that there is partially effective immunity that influences individual level infection incidence.
Sterile protection against malaria can be readily demonstrated in human and animal experimental models 7,18,19 , but not following natural malaria exposure 13 . Field studies showed conflicting evidence on whether naturally acquired immunity can result in delays to patency and showed no evidence for sterile immunity completely preventing the appearance of parasites in the blood stream of exposed individuals 11, 13 . We selected children aged 5-10, who have limited blood stage immunity (a potential confounder when studying pre-erythrocytic immunity) compared to semi-immune adults, and who allow repeated blood sampling compared to toddlers. Since submicroscopic infections are prevalent in the area 20 , we used a curative dose of antimalarials to clear possible sub-patent infections and, upon confirmation that children were parasite-free at the start of the transmission season, assessed the infection incidence by sensitive molecular assays. Our finding that 98% of the cohort became infected with P. falciparum within 3 months confirms the high force of infection in the area.
Consistent with previous sero-epidemiological studies 21-24 , our results indicate that antibodies to P. falciparum sporozoite and liver-stage antigens are acquired following natural exposure. Antibody titres to the CSP antigen were on average low in our cohort and not significantly different from malaria-naive donors. These low titres could be related to the timing of the study recruitment (prior to the transmission season after ~7 months of very low malaria exposure) and may also be influenced by repeated blood-stage infection in our cohort, which may have suppressed immune responses against the pre-erythrocytic stages 25 . To assess the contribution of pre-erythrocytic humoral immunity to protection, previous studies have related antibodies at baseline with time-to-infection after parasite clearance with antimalarials 12 . A significant challenge in these studies is that both protective immunity and cumulative exposure increase with age, and so it is often unclear whether measured responses mediate protection or are merely a marker of past exposure 26, 27 . In an attempt to move beyond indirect epidemiological associations, we explored functional anti-sporozoite immunity by assessing the ability of plasma to inhibit sporozoite gliding motility 28 and hepatocyte invasion 29 and related these in vitro phenotypes to field findings. We observed that CSP IgG antibodies showed a strong positive association with sporozoite gliding motility inhibition. It has been demonstrated that Plasmodium parasites use the system of adhesion-based motility, gliding, to actively penetrate host cells 30 ; and that the invasive ability of sporozoites is directly associated with their motility 31 . In agreement with these findings, the data presented here suggest that in vitro gliding inhibition by naturally acquired antibodies may be a useful surrogate marker for in vitro hepatocyte invasion. In an immuno-epidemiological study undertaken in Indonesia, hepatocyte invasion inhibition was associated with higher anti-CSP antibody titres 32 . In our cohort, subjects with high CSP responses (i.e. higher than the study population median) and those whose plasma more efficiently inhibited sporozoite gliding movement developed P. falciparum infection later compared to children with lower responses. To our knowledge, this is one of the first studies to show that there are functional antibodies against pre-erythrocytic malaria stages in malaria-exposed children.
Our study has several limitations. We observed that high responses in the asexual stage lysate assay with unknown functionality were also associated with longer time to infection. We thus cannot rule out a supportive role for asexual antibody responses in the observed associations 33 . We believe it is likely that the functionally important pre-erythrocytic antibody responses that we quantified here are acquired alongside anti-blood-stage antibodies. In addition, a recent study in the same geographical area demonstrated that heterogeneity in mosquito exposure contributes considerably to heterogeneity in parasite inoculation risk 34 . In the current study, we used delayed time to blood-stage infection as a simplistic indicator of partial protection, which fails to take into account variation in exposure. In an ideal approach, we would have been able to quantify malaria exposure at an individual level, which may involve linking of blood meals in householdcaught mosquitoes to household occupants and determining sporozoites in the salivary glands of these mosquitoes 35 . Measuring exposure at individual level in such an approach will help to shed further light on pre-erythrocytic immunity in naturally exposed individuals. With respect to discriminating between pre-erythrocytic and blood-stage immunity, a valuable but laborious approach would be to examine the observed relationships in a larger cohort that allows stratification based on similar blood stage immunity but different levels of pre-erythrocytic immunity at baseline and that provides sufficient power to detect weaker associations. Another limitation of our study is that we were only able to determine humoral responses. Cellular responses to preerythrocytic stages have been implicated in malaria protection in multiple studies 36, 37 . It is conceivable that by quantifying both antibody and cellular responses we would be able to better define natural immunological phenotypes associated with differential malaria risk 38 .
In summary, in our cohort of children, anti-CSP antibodies were strongly associated with in vitro sporozoite gliding inhibition and hepatocyte invasion inhibition. Children with functional anti-sporozoite antibody responses had a longer time to P. falciparum infection compared to children with lower functional responses, suggesting that these in vitro assays are relevant to understand natural protection. The partial protection (i.e., delay in infection) observed in our study does not prevent individuals from becoming infected during an entire transmission season, but reduces infection incidence and consequently needs to be considered in epidemiological studies aiming to understand malaria risk heterogeneity and in malaria vaccines trials. Identifying host or parasite factors linked to these functional immunological phenotypes and characterizing how these phenotypes change with cumulative exposure to malaria parasites will help the understanding of why natural immunity against pre-erythrocytic stages is incomplete.
Methods
Study design
This study was performed from June to December 2015 in the village of Balonghin in the Saponé health district, Burkina Faso, which is exposed to intense and seasonal P. falciparum transmission
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. Written informed consent was provided by the parent or guardian of each child. The study was approved by the ethics committees of the London School of Hygiene and Tropical Medicine (reference number 9008) and the Ministry of Health in Burkina Faso (reference number 2015-3-033). Children aged 5-10 years with haemoglobin levels above 8 g/dl and no Plasmodium parasites detected by microscopy were eligible. DHA-PQ was used to clear sub-microscopic infections. At 3 weeks (20-22 days) after treatment, finger-prick blood samples were collected to ensure parasite negativity by nested PCR 39 prior to formal enrolment into the cohort. Citrated plasma samples were collected before treatment using citrated vacutainer cell preparation tubes (CPT vacutainers, Becton Dickinson), stored at -80°C and used for malaria-antigen-specific IgG ELISAs and sporozoite assays. Peripheral blood mononuclear cells (PBMC) were also collected, but were lost due to the inability to maintain liquid nitrogen supplies during civil unrest in Ouagadougou. Following enrolment, participants were examined during weekly visits, when finger-prick samples were collected for P. falciparum nested PCR that was performed within 48 hours. Following parasite detection, finger-prick blood samples were collected every day for 1 week, and every week afterwards, up to 35 days after parasite detection. Study participants were closely monitored for the development of malaria symptoms. Artemether-lumefantrine was given upon the detection of symptoms or 35 days after initial detection of infection by nested PCR, whichever came first. For the current analyses, only the time to first infection detection was used and related to baseline immunological assays.
Molecular analyses
Nucleic acids from 100 μl whole-blood samples stored in RNAprotect Cell Reagent were extracted using MagNAPure LC automatic extractor (Total Nucleic Acid Isolation Kit-High Performance, Roche Applied Science) and used for qPCR targeting 18S rRNA 40 . Genomic DNA from the same extraction was used to test for human haemoglobinopathies haemoglobin S and C 41 .
Parasite culture and generation of P. falciparum-infected mosquitoes As source of sporozoites, Anopheles stephensi mosquitoes were infected by standard membrane feeding on P. falciparum NF54 gametocyte cultures 42 . Salivary glands from infected mosquitoes were dissected, collected in Leibovitz culture medium (Lonza) without serum (supplemented with 1% penicillin-streptomycin and 1% L-glutamine for in vitro gliding motility assays), and homogenized in a homemade glass grinder. The number of sporozoites was counted in a Bürker-Türk counting chamber using phase contrast microscopy 18 .
Human hepatoma HC-04 cell line
The HC-04 human hepatoma cell line 29 was acquired through MR4 as part of the Biodefense and Emerging Infections Research Resources Repository (BEI Resources). Hepatoma cells (referred to as hepatocytes) were cultured in Dulbecco's Modified Eagle Medium (DMEM)/Ham's F-12 nutrient mixture medium (GIBCO) supplemented with 10% heat-inactivated fetal bovine serum (FBS, GIBCO), 1% glutamine and 1% penicillin/streptomycin (GIBCO) at 37°C in an atmosphere of 5% CO 2 .
Enzyme-linked immunosorbent assays and sporozoite opsonization assays Levels of antibodies were determined to circumsporozoite protein (CSP: full-length P. falciparum NF54 CSP with repeats, produced in E. coli by Gennova Biopharmaceuticals Ltd., Pune, India), LSA-1 (LSA-NRC construct expressed in E. coli) and asexual lysate using previously reported standardized enzyme-linked immunosorbent assays (ELISAs) 43 ,44 in naturally exposed children (n=51) and malaria-naive European donors (n=9). Antibody levels were calculated in relation to the positive control (hyperimmune plasma pool from Tanzania) that was set at 100 arbitrary units (AU) using Auditable Data Analysis and Management System (ADAMSEL, version 1.1)
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. Recognition of whole sporozoites by naturally acquired IgG and IgM antibodies was determined by an in vitro flowcytometry-based antibody opsonization assay that was presented in detail elsewhere 45 . Flow cytometric analysis was performed with a LSRII flow cytometer (BD BioSciences); data analysis by FlowJo software (version 10.0.8, Tree Star).
Malaria-naive donors are healthy malaria-naive European volunteers who participated in CPS-immunization trial (immunization of malaria-naive human volunteers under chloroquine prophylaxis with sporozoites delivered by mosquito bites) at the Radboud University Medical Center (Nijmegen, The Netherlands) 46 . Written informed consent was obtained from these individuals including for their samples to be stored and used in additional immunological experiments. Pre-immunization samples collected before the CPS-immunization were used for analysis of malaria antigen-specific antibody levels.
In vitro sporozoite gliding motility assay Prior to in vitro sporozoite assays, plasma aliquots were heat-inactivated for 30 minutes at 56°C, centrifuged at 13,000 rpm for 5 minutes at room temperature and kept at 4°C. Flat-bottom optical-bottom 96-well plates with cover glass base were incubated overnight at 4°C with an anti-CSP monoclonal antibody (produced at Radboudumc Nijmegen, Netherlands 47 ) 3SP2; 5 μg/ml in PBS). Following incubation, wells were washed twice with 150 μl/well PBS, blocked for 20 minutes at room temperature with 100 μl/well Leibovitz medium (Lonza) supplemented with 1% penicillin-streptomycin (GIBCO), 1% L-glutamine (GIBCO) and 10% heat-inactivated FBS(GIBCO). P. falciparum NF54 sporozoites (100 μl) were pre-incubated with citrated samples (70 μl; 40% final concentration) for 30 minutes at room temperature and added to each well in triplicate (50 μl/well) at a concentration of 10,000 sporozoites/well. Sporozoites were allowed to glide for 90 minutes at 37°C, 98% humidity, 93% N 2 , 4% CO 2 and 3% O 2 . Wells were washed thrice with 100 μl/well PBS and gliding trails were fixed for 15 minutes at room temperature with 4% paraformaldehyde (Affymetrix). Following fixation, wells were washed thrice with 100 μl/well PBS and blocked with 150 μl/well 10% FBS/PBS for 20 minutes at room temperature. Subsequently, gliding trails were stained for 1 hour at room temperature with 50 μl/well 5 μg/ml biotinylated anti-CSP monoclonal antibody (anti-CSP 3SP2 antibodies were produced at Radboudumc, Nijmegen, the Netherlands 47 ), followed by a wash step (thrice with PBS) and a 1 hour incubation at room temperature with 50μl/well 10 μg/ml streptavidin-Alexa Fluor-594 (Life Technologies) diluted in 10% FBS in PBS. Subsequently, wells were washed thrice with 100 μl/well PBS and stored in 150 μl/well PBS at 4°C in the dark until analysis. Gliding trails were imaged automatically with the BioTek Cytation cell imager (25 images per well at 200x magnification) and images were analysed automatically by FIJI software (under ImageJ version 2.0.0-rc-68/1.52h) with Otsu's thresholding 28 . Results were plotted in GraphPad Prism version 5.03.The number of pixels present on a stitched image made from 25 individual pictures taken per well is a measure of the amount of shed CSP in that particular well and therefore, differences in the number of pixels can be interpreted as differences in sporozoite gliding trail surface 28 .
In vitro sporozoite infectivity assay of a human hepatoma cell line Neutralization of P. falciparum sporozoite hepatocyte invasion by naturally acquired antibodies was assessed in a flow-cytometry-based in vitro invasion assay, as previously described 45 . Flow cytometric analysis was performed with a Gallios (Beckman Coulter) flow cytometer and data were analysed with FlowJo software (version 10.0.8, Tree Star). The percentage of CSP-positive hepatocytes was first corrected for background reactivity by subtracting the background (uninfected HC-04 cells in the presence of 3SP2-Alexa Fluor-488 antibody). The percent invasion inhibition was expressed relative to control IgG.
Statistical analysis
For analysis of in vitro sporozoite data, comparisons between two (controls versus field samples) or multiple groups were performed using Mann-Whitney U-test and Kruskal-Wallis test followed by Dunn's test between two groups, respectively. The associations between immune responses and malaria infection risk were assessed using survival analysis methods. Log-rank test was used to compare times to infection incidence for individuals with different values of immune phenotypes. Cox survival models were fit to assess the effect of pre-erythrocytic immunity after adjustment for blood-stage immunity; the proportional hazards assumption was tested using Schoenfeld residuals. In these analyses, study participants were considered to have high or low responses (binary explanatory variables) based on the study population median (see Figure S4 in Extended data 14 ). The first scheduled weekly visit or intensive follow-up visit when parasitaemia of at least 0.1 parasites per μl was detected by 18S qPCR was considered the time of infection incidence. This threshold of parasitaemia was chosen to minimise false-positive results. In the supplemental material, sensitivity analyses were included that used different cut-offs of 18S qPCR-based density to determine infection positivity. Stata 14 (StataCorp LP, Texas, USA) and GraphPad Prism software (version 5, GraphPad Software Inc., California, USA) were used for statistical analysis. P<0.05 was considered statistically significant.
Data availability Underlying data
The main dataset relating to the field study contains individual level data and identifying information on participants; as such, this dataset is stored under restricted access and not available through an open-access repository. Requests from researchers to access these data for pooled or meta-analysis should be addressed to the corresponding author (teun.bousema@radboudumc. nl). However, the dataset used in the survival analysis has been de-identified and is available from the Dryad repository, along with raw ELISA results and sporozoite gliding data. DOI: https://dx.doi.org/10.5061/dryad.n1m33qq 14 .
Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
Extended data
The results of sensitivity analyses (see Results section) and Figures S1-4 are available from the Dryad repository. . The y-axes in these panels represent the percentages of study population with various levels of responses. In (A) and (B), one and seven individuals had undetectable responses and, to be included in this figure, were assigned response values equivalent to half of the lower limit of detection. In (D), the results of gliding assays are presented: the left plot presents the distribution of log 10 -transformed sporozoite gliding surface; the right plot shows gliding inhibition (y-axis) for each study participant (different bars; x-axis). The median gliding inhibition (59.6%) was used to define high and low inhibition in the survival analysis. The study by Barry and colleagues is important to shed more light into the efficiency of naturally-acquired sporozoite immunity to interfere with the parasite development at the pre-erythrocytic stages. Functional antibodies are assessed in plasma from exposed children for their capacity to in vitro P. falciparum interfere with sporozoite gliding and hepatocyte invasion which are required for progress with their life cycle to liver and blood stages, and these are related to titers. The outcome measured is blood stage parasitemia (delay of appearance of subpatent infections) as no direct measurement of liver parasitemia can be done in humans.
Some changes are required to clarify some aspects and make the work more scientifically sound:
ABSTRACT
In the Abstract background, specify if the statement "it is unclear whether immunity that affects the establishment of infections develops following continuous natural exposure" refers to children or in general, and if it refers to naturally acquired immunity as typically perceived (mostly against blood stages) or here if specific for pre-erythrocytic immunity. This also applies to the main Introduction. Although sterilizing immunity does not develop, parasite densities tend to decrease with age.
In the Abstract Methods it would be relevant to specify the intensity of malaria transmission and the specific area of study (location) within Burkina Faso, to know how repeatedly are they exposed to Pf. Also clarify if it is qPCR or nested PCR (also in results, it is a bit confusing when each is used). Liver stage antigen: which one? Specify also that the functional sporozoite assays are .
in vitro
In the results, mention if CSP antibody titres correlated with hepatocyte invasion and if the latter correlated to delayed time to qPCR +ve.
INTRODUCTION
See comments in the Abstract section.
METHODS
Can it be clarified if children did not receive antimalarial treatment, if during the weekly monitoring visits the nested PCR (done 48h after bleeding) was Pf positive but they had no symptoms (at least for 35 days)? If so, this was accepted by ethics committees easily? Were the families visits the nested PCR (done 48h after bleeding) was Pf positive but they had no symptoms (at least for 35 days)? If so, this was accepted by ethics committees easily? Were the families communicated of a positive PCR reaction in absence of symptoms? Indicate where the sporozoites were generated. Indicate if and how the patent parasitemias were also monitored and taken into account in the analysis.
RESULTS
When presenting data on median invasion inhibition, please comment on whether these % are high, moderate or low, and give some references.
The following statement does not look convincing by looking at the Fig S3A scatter plot despite the P=0.02 and Spearman's ρ=0.60 that appears driven by exteme values: "There was a positive correlation between gliding and invasion inhibition suggesting that gliding inhibition by in vitro naturally acquired antibodies might serve as a good surrogate for hepatocyte invasion in vitro inhibition." The correlation in Fig S3B is clearer. Fig 3A: interesting to see that there is not always overlap of the three metrics, expected to be discussed. Why was hepatocyte invasion inhibition not included? Explain the rationale for categorizing in high and low responders. Was the analysis also done with continuous values but did not yield significant insights? The joint analysis of the antibody levels to CSP and blood stage lysate and the functional pre-erythrocytic responses is helpful, but shouldn't there be a model with the 3-4 responses together? If not, explain why.
DISCUSSION
It is not convincing to say that children 5-10 years in a highly endemic area of Burkina Faso have limited blood stage immunity. They will have quite high antibody responses to blood stage antigens already. Better to reformulate. It is surprising the lack of difference in antibody levels for CSP between these children and naive volunteers. Even if CSP is not as highly immunogenic as many blood stage antigens, the responses are usually significant and detectable, even in children. Could there be a problem with the capture antigen? Seasonality by itself may not totally explain this, or it would imply they are very short lived. The potential inhibition by blood stage has been proposed but it would also affect LSA1. It is not well discussed how the affection of gliding and invasion before liver stage is detected as delay in positive qPCR in the blood, how do authors think this works
As mentioned, the study is valuable due to the lack of data on functional pre-erythrocytic antibody responses in exposed African children. infections, then attempts to explain delays in time to infection in terms of Plasmodium falciparum antibodies against circumsporozoite protein (CSP) and whole parasites. The authors demonstrate that, in individuals who show greatest delays in time to parasitemia, there were stronger functional antibody responses against sporozoites which reduced gliding motility and liver cell invasion . The major in vitro question addressed in this ms is whether these anti-sporozoite responses are affecting time to parasitemia in these children. From the data presented, the answer is "maybe". The problem the authors face is that for almost every infection that stimulates anti-sporozoite antibodies, that infection also stimulates blood stage antibodies as the infection progresses. It is these latter that show the best negative correlation in reduction in time to parasitemia, and while separating out the functional anti-sporozoite effects is informative it is not definitive. This is illustrated in Figure 3A , where of the 29 participants with anti-sporozoite functional activities in one or both of the assays, 17 also have higher than median anti-blood stage responses. I do not see a way around this at the participant level and the authors clearly acknowledge this difficulty in their discussion; one is trying to see subtle effects on infection (in this case time to infection no children we uninfected during the study) using markers that autocorrelated and cannot therefore be separated from one another in terms of cause and effect. One additional complication is not considered as far as I can tell. In order to have become infected, these children must have been bitten by mosquitoes. The mosquito bites induce antibody responses. The sporozoites used in the assays for gliding motility and hepatocyte invasion were from crude homogenates that contain salivary gland material. It is possible (though I admit not too likely) that there was some functional interaction between these two. Could antibodies against ( ) salivary glands Anopheles stephensi be present in these sera (of children bitten by African anophelines), and if so, could they have affected the functional antibody assays? in vitro Nevertheless, the ms provides important information concerning anti-sporozoite functional antibodies, even if a clinical outcome (delayed time to parasitemia) cannot be ascribed to them.
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even if a clinical outcome (delayed time to parasitemia) cannot be ascribed to them. :
Other points
Given the comments above and the stronger correlation of blood stage antibodies with delay to parasitemia, the authors should consider changing the abstract (and perhaps the title) to include this information. It is buried in the paper but should be more explicit. At the start of the introduction, the authors highlight the protective efficacies of RTS,S and PfSPZ Vaccine. However, they should also note that the outcomes, efficacies are different, RTS,S being time to clinical malaria, PfSPZ Vaccine being time to parasitemia. This has direct relevance to the ms. Also in the introduction, the authors suggest that there is a discrepancy between protection with sporozoites and naturally induced protection not preventing infection. In this manuscript Barry, Behet and colleagues address an important question aiming to possibly appoint an effective role in protection from clinical malaria to liver-stage immunity acquired naturally in malaria endemic areas. I believe the work presented is a significant contribution to our understanding of naturally acquired immunity to pre-erythrocytic stages of and I make a few comments and P. falciparum suggestions that may improve the current version of the manuscript. The data shows that ABs developed during past malaria cases can reduce sporozoite motility and hepatocyte invasion suggesting that ABs acquired during natural infections can reduce new in vitro liver-stage infections. However, the contribution of a possible similar effect is, in my view, less clear in vivo from the data presented, and more caution may be needed to discuss the results. All the children followed throughout the study became parasite positive by qPCR, indicating that even children with strong inhibiting ABs were unable to block liver-stage infection efficiently. Furthermore, high response to asexual might be confounding the analysis. I would add to the manuscript (or supplemental) figures stage lysate the association of CSP ABs with asexual stage lysate ABs, and also the association of whole SPZ ABs with asexual stage lysate ABs, to give the reader an idea of how close these parameters are.
I also suggest including, if that has not been done already, the in the multivariate Reported bed net use I also suggest including, if that has not been done already, the in the multivariate Reported bed net use analyses, as this could also be a factor increasing time to PCR positive and clinical malaria.
The authors cite the study by Tran et al. where it was shown that, in Mali, time to PCR positive was independent of age, while time to clinical malaria increased with age, and where as stated it was concluded that there no or very limited evidence for an age dependent acquisition of immunity protecting Similarly, in the present manuscript, functional data of higher humoral response from infection.
in vitro against pre-erythrocytic stages does not (independently of blood-stage immunity) protect from infection. So, I would rephrase the last sentence in first paragraph of the discussion to add a bit more caution in interpreting what may be causing partial protection.
At the end of section the authors should, in Evidence of natural risk-modifying pre-erythrocytic immunity my view, clearly state that does not independently associate in a statistically High gliding inhibition activity significant way, with on the multivariate analyses where blood stage protection against falciparum infection immunity was included; the P value is above 0.05 (0.055) and the CI includes 1, making the relative risk not statistically significant.
I believe the manuscript could be improved by presenting the quantitative analysis of the qPCR upon 18s first parasite detection and determine if there is a negative association with the inhibitory capacity of the individuals' ABs. It would also be very interesting to question if time from first PCR positive to time of presentation of symptoms is different between poor and strong inhibitors. If the data in vitro in vitro showing gliding inhibition and reduced hepatocyte invasion are significant , one would expect a in vivo lower inoculum in the liver and thus a lower parasitaemia on the first PCR positive time-point. And then potentially a slower progression to clinical malaria. I believe with the data generated in this manuscript these analyses could be done, and would enrich the story.
It is not totally clear to me how individuals were selected for the flow cytometry assays. Survival, gliding inhibition, CSP, LSA1 and asexual lysate ELISAs were performed for the 51 participants, but flow cytometry data presented in fig2 D and E was obtained from 17 Burkinabes only; how were those selected and what is their time to PCR+ in the survival analysis. If they are the 8 poor and 8 strong inhibitors as defined by their gliding inhibition it should be stated in the methods (seems to be so, given supFig3, but there is one extra?). I also suggest to pinpoint these 8 poor and 8 strong inhibitors in fig1 so that the reader would be informed of their time to PCR+ and time to malaria symptoms. I would be more cautious when citing ref 31, I believe the study by Michael Stewart et al. shows that non-motile SPZ are unable to invade, but is not clearly showing a direct association between % of human AB affecting motility and those levels correlating directly with invasion either.
Minor points: In table 1, I would not refer to the 6 children who were PCR positive at the 3 weeks after treatment time-point as as I do not think that it can be excluded that the children Persisting parasites post-treatment were re-infected after clearance of PQ. I recommend adding a brief description of the method in ref 45 in the section In vitro sporozoite infectivity inmaterial and methods. assay of a human hepatoma cell line On page 3 below table 1 there is mention to which may be a mistake. field PCR The data from the gliding inhibition by LSA IgG seems to be not shown. I think it should be clarified in vitro in the text that that is indeed the case. Likewise, if the LSA-1-specific IgG antibodies correlation with sporozoite invasion inhibition is data not shown I would clearly state it in the text.
In figS2A I would specify that is IgG in the figure x axis and use the label CSP IgG titer instead of CSP 
